Trial site
Instituto De Investigaciones Clinicas Quilmes
- 9running trials
- 4closed trials
The trials here
What the 13 trials at this site are about, from their registry records.
- Conditions
- Lupus (SLE)4 trials
- Ulcerative colitis4 trials
- Alzheimer disease1 trial
- Atrial fibrillation1 trial
- Chronic kidney disease1 trial
- Coronary artery disease1 trial
- Heart failure1 trial
- High blood pressure1 trial
- Obesity1 trial
- Peripheral artery disease1 trial
- Psoriasis1 trial
- Psoriatic arthritis1 trial
- and 3 more
- Phase
- Phase 310 trials
- Phase 22 trials
- Phase 2/31 trial
- Status
- Active, not recruiting6 trials
- Completed4 trials
- Recruiting3 trials
- Lead sponsor
- Eli Lilly and Company3 trials
- Janssen Research & Development, LLC3 trials
- Abivax S.A.2 trials
- Biogen1 trial
- Boehringer Ingelheim1 trial
- and 3 more
Running trials
Recruiting
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
Recruiting
Recruiting
A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lupus (SLE)2 recruiting
- Ulcerative colitis1 recruiting
Closed trials
Completed
Efficacy and Safety of Seralutinib in Adult Subjects With PAH (PROSERA)
Completed
Completed
ABTECT-1 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -1
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026